MedPath

Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes

Not Applicable
Not yet recruiting
Conditions
Kidney Stone
Nephrolithiasis
Interventions
Device: INTRARENAL PRESSURE MONITORING VISIBLE
Registration Number
NCT06576661
Lead Sponsor
University of Kansas Medical Center
Brief Summary

The goal of this study is to evaluate the influence of real-time intrarenal pressure measurement availability on surgeons' behavior during ureteroscopy while using the ureteroscope LithoVue Elite.

Detailed Description

Despite advances in surgical techniques and technology, preventable adverse events still occur in the operating room, with half of them attributed to poor non-technical skills of surgical teams. Therefore, it is essential to observe and measure surgeons' intraoperative non-technical skills and provide structured feedback to improve patient safety. The new LithoVue Elite™ disposable ureteroscope has the potential to impact surgeons' behavior during ureteroscopy, as it enables the measurement of real-time intrarenal pressures. We designed a study to to evaluate urologists' behavior during ureteroscopic stone treatment with and without intra-renal pressure monitoring.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Males or females over 18 years of age
  • Undergoing flexible ureteroscopy to address urinary stones located in the proximal ureter or kidney
  • Total stone burden over 2 cm
Exclusion Criteria
  1. Undergoing bilateral stone treatment during the same procedure
  2. Patients with known genitourinary anatomical abnormalities
  3. Uncorrected coagulopathy
  4. Patients with urinary diversions
  5. Chronic external urinary catheters
  6. Women who are pregnant
  7. Immunosuppressed patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
URS WITH INTRARENAL PRESSURE MONITORING VISIBLEINTRARENAL PRESSURE MONITORING VISIBLEIn Arm 1, participants will undergo URS with real-time IRP monitoring visible to surgeons using the LithoVue Elite™. Participants will be scheduled to undergo URS per standard of care. All follow-up visits will be scheduled per standard of care.
Primary Outcome Measures
NameTimeMethod
Surgeon behavior as measured by mean Non-Technical Skills for Surgeons (NOTSS) score.Procedure

Treating investigators will be evaluated using the modified NOTSS tool during the procedure. The NOTSS is used to measure non-technical skills in the operation room in the following categories; situation awareness, decision making, communication \& teamwork, and leadership.

Secondary Outcome Measures
NameTimeMethod
Difference in decision-making domain scores as measured by the Non-Technical Skills for Surgeons (NOTSS) scoresProcedure

Treating investigators will be evaluated using the modified NOTSS tool during the procedure. The NOTSS is used to measure non-technical skills in the operation room in the following categories; situation awareness, decision making, communication \& teamwork, and leadership.

Post-operative infection30-days post-operative

Patient signs and symptoms concerning for a urinary tract infection, along with a positive urine culture

Perioperative patient outcomes as measured by Clavien-Dindo classification systemUp to 30 days

Intraoperative complications will be categorized based on the Clavien-Dindo classification system

Post-operative pain as measured by Visual analog scale (VAS)Immediately post-operative and up to 7 days

The VAS is a valid and reliable method for quantifying pain intensity on a scale of 0 to 10, where 0 represents no pain and 10 represents the most severe pain possible.

Post-operative pain as measured by opioid useImmediately post-operative and up to 7 days

Opioid usage will be tracked

Trial Locations

Locations (1)

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath